Detalles de la búsqueda
1.
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.
Blood;
139(25): 3605-3616, 2022 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316328
2.
Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients.
Transpl Infect Dis;
23(1): e13453, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860467
3.
Copper 64-labeled daratumumab as a PET/CT imaging tracer for multiple myeloma.
Blood;
131(7): 741-745, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29301755
4.
Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor.
Hematol Oncol;
35(3): 281-287, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26928577
5.
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
22(2): 268-276, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26325438
6.
Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
21(7): 1326-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25842050
7.
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma.
Biol Blood Marrow Transplant;
21(12): 2136-2140, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26211987
8.
Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphoma.
Biol Blood Marrow Transplant;
20(11): 1864-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25008328
9.
Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimen.
Biol Blood Marrow Transplant;
20(12): 2072-5, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25079874
10.
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma.
Blood;
119(26): 6379-81, 2012 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22611160
11.
Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes.
J Immunol Sci;
7(1): 9-27, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996290
12.
Matched-cohort analysis of autologous hematopoietic cell transplantation with radioimmunotherapy versus total body irradiation-based conditioning for poor-risk diffuse large cell lymphoma.
Biol Blood Marrow Transplant;
18(3): 441-50, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21801706
13.
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.
Blood;
115(5): 1098-105, 2010 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-19965688
14.
Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in Remission.
Transplant Cell Ther;
28(7): 368.e1-368.e7, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35398328
15.
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.
Biol Blood Marrow Transplant;
17(10): 1481-9, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21338704
16.
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.
Blood;
113(25): 6465-76, 2009 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-19369230
17.
Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma.
Ann Hematol;
90(7): 803-8, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21210120
18.
HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL).
Biol Blood Marrow Transplant;
16(9): 1302-8, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20353830
19.
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.
Blood;
112(3): 903-9, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18519812
20.
Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.
Biol Blood Marrow Transplant;
15(11): 1407-14, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19822300